2-hydroxyacetyl-7-acetylxanthone

Suppliers

Names

[ CAS No. ]:
125769-47-3

[ Name ]:
2-hydroxyacetyl-7-acetylxanthone

Chemical & Physical Properties

[ Density]:
1.383g/cm3

[ Boiling Point ]:
540.7ºC at 760mmHg

[ Molecular Formula ]:
C17H12O5

[ Molecular Weight ]:
296.27400

[ Flash Point ]:
204.8ºC

[ Exact Mass ]:
296.06800

[ PSA ]:
84.58000

[ LogP ]:
2.32380

[ Vapour Pressure ]:
1.59E-12mmHg at 25°C

[ Index of Refraction ]:
1.639

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ZD5711800
CHEMICAL NAME :
9H-Xanthen-9-one, 2-acetyl-7-(hydroxyacetyl)-
CAS REGISTRY NUMBER :
125769-47-3
LAST UPDATED :
199103
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C17-H12-O5
MOLECULAR WEIGHT :
296.29

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FRMCE8 Farmaco. (Societa Chimica Italiana, Corso Strada Nova, 86, Casella Postale 227, 27100 Pavia, Italy) V.44- 1989- Volume(issue)/page/year: 44,547,1989
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FRMCE8 Farmaco. (Societa Chimica Italiana, Corso Strada Nova, 86, Casella Postale 227, 27100 Pavia, Italy) V.44- 1989- Volume(issue)/page/year: 44,547,1989

Related Compounds

  • 2,7,9-trimethyl-3-[(E)-(2-nitrophenyl)methylideneamino]pyrido[2,3]thieno[2,4-d]pyrimidin-4-one
  • 2-(7-oxabicyclo[2.2.1]hept-2-en-5-yl)-1H-imidazole
  • 2,7-DIMETHYLQUINOLINE-4-CARBOXYLIC ACID
  • 2,7-Naphthyridine-1,3(2H,7H)-dione,2-[2-(1H-indol-3-yl)ethyl]-7-(phenylmethyl)-
  • 2,7-dibromoacridine-3,6-diamine
  • 2,7-dichloro-10,10-dioxo-9H-thioxanthene-3,6-diamine
  • 3,4,5-trimethoxy-N-[2-(2-methyl-4-oxoquinazolin-3(4H)-yl)ethyl]benzamide
  • 1-methyl-N-[2-(2-methyl-4-oxoquinazolin-3(4H)-yl)ethyl]-1H-indole-2-carboxamide
  • 1-methyl-N-[2-(4-oxoquinazolin-3(4H)-yl)ethyl]-1H-indole-3-carboxamide
  • (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methyl-N-(3,4,5-trimethoxyphenyl)hex-4-enamide
  • (E)-N-(5-cyclobutyl-1,3,4-thiadiazol-2-yl)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enamide
  • (E)-N-(4,5-dimethylthiazol-2-yl)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enamide
  • (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methyl-N-(3-methylbutyl)hex-4-enamide
  • 4,8,8-trimethyl-5-[2-(morpholin-4-yl)-2-oxoethoxy]-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-2-one
  • 3,4-dimethoxy-N-[2-(4-oxoquinazolin-3(4H)-yl)ethyl]benzamide
  • N-[2-(1H-imidazol-4-yl)ethyl]-2-methyl-1-oxo-1,2-dihydroisoquinoline-4-carboxamide